Crunching the numbers: trademark activity during COVID-19

Robert Reading, director of professional services and strategy at CompuMark (part of Clarivate), looks at COVID-19’s impact on pharmaceutical and medical trademark activity – and reveals some surprising findings
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: